Maria Nirvana Formiga, MD, PhD (@nirvanaformiga) 's Twitter Profile
Maria Nirvana Formiga, MD, PhD

@nirvanaformiga

Medical Oncologist @A.C.Camargo Cancer Center #oncogenetics #GUoncology #sarcoma

ID: 962110300769091589

calendar_today09-02-2018 23:45:45

214 Tweet

528 Followers

231 Following

Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

A historic day for #kidneycancer & the field of #oncology as a whole at ASCO #GU24. Toni Choueiri, MD Dana-Farber & colleagues present the 1st randomized phase 3 study to show a survival advantage w adjuvant PD1 inhibition, reinforcing this approach as SOC. Proud of his tireless

A historic day for #kidneycancer &amp; the field of #oncology as a whole at <a href="/ASCO/">ASCO</a> #GU24. <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/DanaFarber/">Dana-Farber</a> &amp; colleagues present the 1st randomized phase 3 study to show a survival advantage w adjuvant PD1 inhibition, reinforcing this approach as SOC. Proud of his tireless
Maria Nirvana Formiga, MD, PhD (@nirvanaformiga) 's Twitter Profile Photo

A Phase III Randomized Study (PIVOT-09) | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… Honored to have participated in this #RCC trial BI BOB With big #GU oncologists Dr. Tannir MD Anderson Cancer Center Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Dan George and others

Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

Huge congrats to #NizarTannirMD MD Anderson Cancer Center who drove forward this impt trial (#PIVOT09) comparing pegylated #IL2/#nivolumab to #TKI; was a privelege to work w him & others (Maria Nirvana Formiga, MD, PhD Neeraj Agarwal, MD, FASCO Dan George) on this trial now in Journal of Clinical Oncology. PFS & OS no different;

Huge congrats to #NizarTannirMD <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> who drove forward this impt trial (#PIVOT09) comparing pegylated #IL2/#nivolumab to #TKI; was a privelege to work w him &amp; others (<a href="/nirvanaformiga/">Maria Nirvana Formiga, MD, PhD</a> <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> <a href="/Daniel_J_George/">Dan George</a>) on this trial now in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>. PFS &amp; OS no different;
Maria Nirvana Formiga, MD, PhD (@nirvanaformiga) 's Twitter Profile Photo

Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival doi.org/10.31744/einst… influence of drug access on #overalsurvival #prostatecancer Luciana Holtz Stenio Zequi